Mail

UK markets close in 2 hours 40 minutes

FTSE 100
7,942.65
+57.48(+0.73%)
FTSE 250
20,348.92
+45.11(+0.22%)
AIM
882.01
-1.22(-0.14%)
GBP/EUR
1.1297
+0.0033(+0.29%)
GBP/USD
1.2180
+0.0110(+0.91%)
BTC-GBP
18,657.04
-428.89(-2.25%)

Fall head over hills in love with these

10 romantic homes to swoon over

Jazz Pharmaceuticals plc (JAZZ)

NasdaqGS - NasdaqGS Real-time price. Currency in USD

Add to watchlist

151.00

-3.51

(-2.27%)

At close: 04:00PM EST

151.00

0.00

(0.00%)

Pre-market:

07:14AM EST

Currency in USD

Valuation measures⁴

Market cap (intra-day)	9.80B
Enterprise value	14.72B
Trailing P/E	N/A
Forward P/E	9.12
PEG ratio (5-yr expected)	4.00
Price/sales (ttm)	2.73
Price/book (mrq)	3.57
Enterprise value/revenue	4.11
Enterprise value/EBITDA	16.83

Trading information

Stock price history

Beta (5Y monthly)	0.71
52-week change ³	5.45%
S&P500 52-week change ³	-8.57%
52-week high ³	169.98
52-week low ³	125.36
50-day moving average ³	155.50
200-day moving average ³	150.49

Share statistics

Avg vol (3-month) ³	546.38k
Avg vol (10-day) ³	424.3k
Shares outstanding ⁵	62.97M
Implied shares outstanding ⁶	N/A
Float ⁸	61.22M
% held by insiders ¹	2.51%
% held by institutions ¹	96.92%
Shares short (12 Jan 2023) ⁴	2.63M
Short ratio (12 Jan 2023) ⁴	4.04
Short % of float (12 Jan 2023) ⁴	4.78%
Short % of shares outstanding (12 Jan 2023) ⁴	4.17%
Shares short (prior month 14 Dec 2022) ⁴	2.23M

Dividends & splits

Forward annual dividend rate ⁴	N/A
Forward annual dividend yield ⁴	N/A
Trailing annual dividend rate ³	0.00
Trailing annual dividend yield ³	0.00%
5-year average dividend yield ⁴	N/A
Payout ratio ⁴	0.00%
Dividend date ³	N/A
Ex-dividend date ⁴	N/A
Last split factor ²	N/A
Last split date ³	N/A

Financial highlights

Fiscal year

Fiscal year ends	30 Dec 2021
Most-recent quarter (mrq)	29 Sept 2022

Profitability

Profit margin	-0.52%
Operating margin (ttm)	27.02%

Management effectiveness

Return on assets (ttm)	5.30%
Return on equity (ttm)	-0.56%

Income statement

Revenue (ttm)	3.58B
Revenue per share (ttm)	57.66
Quarterly revenue growth (yoy)	12.20%
Gross profit (ttm)	2.88B
EBITDA	1.62B
Net income avi to common (ttm)	-18.69M
Diluted EPS (ttm)	-7.37
Quarterly earnings growth (yoy)	N/A

Balance sheet

Total cash (mrq)	899.36M
Total cash per share (mrq)	14.28
Total debt (mrq)	5.81B
Total debt/equity (mrq)	211.81
Current ratio (mrq)	3.16
Book value per share (mrq)	43.65

Cash flow statement

Operating cash flow (ttm)	1.11B
Levered free cash flow (ttm)	1.54B